Abstract
The only curative treatment option for patients with end-stage lung disease is lung transplantation, since no curative pharmacological drug for diseases is known so far. In order to analyze the effect of new drugs on diseased tissue and vasculature, we developed an ex vivo lung perfusion (EVLP) setup, in which explanted diseased lungs from lung transplant recipients cab be treated with new drugs whilst undergoing normothermic perfusion and ventilation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
